DocuSign (DOCU) shares plunged 17.01% in after-hours trading on Thursday, following the release of its first-quarter fiscal 2026 results. Despite beating earnings expectations, the e-signature company's stock took a hit due to disappointing billings and a trimmed full-year outlook.
For Q1, DocuSign reported adjusted earnings of $0.90 per share, surpassing the analyst consensus of $0.81. Revenue came in at $763.7 million, up 7.6% year-over-year and beating expectations of $748.13 million. However, billings, a key metric for future revenue, rose only 4% to $739.6 million, falling short of the company's projected range of $741 million to $751 million.
The company's outlook also contributed to the stock's decline. DocuSign lowered its full-year billings forecast to around $3.3 billion, down from its previous projection of up to $3.4 billion. While the company raised its fiscal 2026 revenue guidance to $3.15-$3.16 billion, up from $3.13-$3.14 billion, it appears this wasn't enough to offset concerns about slowing growth and competitive pressures in the digital signature market. The sharp stock decline suggests investors may be worried about DocuSign's long-term growth prospects and its ability to maintain its market position in an increasingly competitive landscape.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.